Cargando…
Intravenous Thrombolysis for Acute Ischemic Stroke Due to Cardiac Myxoma
BACKGROUND: Myxoma may cause systemic embolization and frequently presents as ischemic stroke. CASE PRESENTATION: There have been debates about whether it is safe to use recombinant tissue plasminogen activator (rt-PA) in patients with cardiac myxoma who referred with ischemic stroke to the hospital...
Autores principales: | Esmaeili, Sara, Shojaei, Seyedeh Fahimeh, Bahadori, Maryam, Mojtahed, Mohammad, Mehrpour, Masoud |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Iranian Neuroscience Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8019853/ https://www.ncbi.nlm.nih.gov/pubmed/33850622 http://dx.doi.org/10.32598/bcn.11.6.1844.1 |
Ejemplares similares
-
Factors predicting the outcome of intravenous thrombolysis in stroke patients before rt-PA administration
por: Mehrpour, Masoud, et al.
Publicado: (2019) -
Intravenous Thrombolysis for Embolic Stroke due to Cardiac Myxoma
por: Sun, Mu-Chien, et al.
Publicado: (2011) -
Thrombolytic treatment in stroke mimic, inevitable but fortunately safe: An observational study from Iran
por: Esmaeili, Sara, et al.
Publicado: (2019) -
A case of aberrant bilateral vertebral arteries orgin presenting with right VA dissection
por: Bahadori, Maryam, et al.
Publicado: (2020) -
Intravenous thrombolysis in a patient with left atrial myxoma with acute ischemic stroke
por: Kulkarni, Girish Baburao, et al.
Publicado: (2014)